Company
United StatesPublic company, NASDAQ: BCRXBiocryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Birmingham, AL – FDA Inspections
Inspection records and compliance data for Biocryst Pharmaceuticals, Inc. in Birmingham, Alabama. 1 FDA inspection on record, last inspected May 26, 2009. Publicly traded as NASDAQ: BCRX.
Company Profile
This profile covers Biocryst Pharmaceuticals, Inc. based in Birmingham, Alabama, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected May 26, 2009.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 26, 2009 | NAI | Human Drugs · Drug Quality Assurance | 580980 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Biocryst Pharmaceuticals, Inc.
Stock ticker
BCRX
Exchange
NASDAQ
Share price
$7.59
Market cap
$2.0B
Price as of
November 6, 2026
FEI Number
1000524826
Address
2190 Parkway Lake Dr, Birmingham, Alabama 35244, United States
Country
United States
ID: 8b85e55e-d207-4d5d-9254-aaa84d325634